Details for New Drug Application (NDA): 074565
✉ Email this page to a colleague
NDA 074565 describes SELEGILINE HYDROCHLORIDE, which is a drug marketed by Apotex, Lannett Co Inc, Novitium Pharma, Rising, Apotex Inc, Chartwell Molecules, Cosette, Dash Pharms Natco, G And W Labs Inc, I3 Pharms, Kenton, and Norvium Bioscience, and is included in fourteen NDAs. It is available from ten suppliers. Additional details are available on the SELEGILINE HYDROCHLORIDE profile page.
The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Summary for 074565
| Tradename: | SELEGILINE HYDROCHLORIDE |
| Applicant: | Chartwell Molecules |
| Ingredient: | selegiline hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 074565
| Mechanism of Action | Monoamine Oxidase Inhibitors Monoamine Oxidase-B Inhibitors |
Suppliers and Packaging for NDA: 074565
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074565 | ANDA | Chartwell RX, LLC | 62135-694 | 62135-694-60 | 60 TABLET in 1 BOTTLE (62135-694-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Aug 2, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
